teleABLE to Reduce Post-Stroke Sedentary Behavior

Last updated: March 21, 2025
Sponsor: University of Minnesota
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Treatment

teleABLE (telehealth-delivered Activating Behavior for Lasting Engagement)

Health Education

Clinical Study ID

NCT06312709
STUDY00021288
K23HL159240
  • Ages > 18
  • All Genders

Study Summary

The goal of this clinical trial to test whether a remotely delivered behavioral activation-based intervention called "teleABLE" works better than a health education intervention for (1) reducing sitting time and (2) improving health-related quality among adults who were diagnosed with stroke within the past 12 months.

Participants in this study will:

  • Complete questionnaires at Weeks 1, 8, and 24

  • Wear an activPAL monitor at Weeks 1, 8, and 24

  • Participate in the teleABLE intervention (12 sessions) or the health education intervention (6 sessions)

  • Complete an interview at Week 24

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: 18 years or older

  • Diagnosis: Stroke diagnosis ≤12 months prior to study enrollment

  • ≥6 hours of sedentary behavior on a typical weekday (Sedentary BehaviorQuestionnaire)

  • Able to walk 150 feet or more without physical assistance from another person, withor without assistive device (assessed by Functional Independence Measure, mobilityscore ≥5)

  • Able to access an electronic device (smartphone, tablet, or computer) that iscompatible with a videoconferencing application

  • Able to identify a support person with whom they have a face-to-face interaction atleast one time per week.

  • Able and willing to participate fully in the study and provide informed consent

Exclusion

Exclusion Criteria:

  • Currently receiving care in an inpatient rehabilitation, transitional care unit, orskilled nursing facility

  • Severe cognitive or communication impairments (inability to respond accurately tocomplete study telephone screening or complete informed consent)

  • Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis,amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease,Huntington's disease, glioblastoma)

  • Comorbid cancer, currently undergoing chemotherapy or radiation treatment

  • Comorbid major depressive disorder (Patient Health Questionnaire-2, score ≥2)

  • Received inpatient treatment or hospitalized for psychiatric condition and/oralcohol or substance abuse within the past 12 months

  • Diagnosis of a terminal illness and/or currently receiving hospice care

  • Currently pregnant or expecting to become pregnant in the next 6 months

  • History of skin sensitivity that precludes the use of medical tape necessary foradherence to activity monitor measure

  • Inability to speak, read, or understand English

  • Concurrent participation in any other rehabilitation intervention research study (including cognitive and/or physical rehabilitation studies)

  • Investigator discretion for safety or adherence reasons

Study Design

Total Participants: 92
Treatment Group(s): 2
Primary Treatment: teleABLE (telehealth-delivered Activating Behavior for Lasting Engagement)
Phase:
Study Start date:
April 04, 2024
Estimated Completion Date:
July 31, 2026

Connect with a study center

  • School of Kinesiology, University of Minnesota

    Minneapolis, Minnesota 55455
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.